期刊文献+

缺血修饰白蛋白与急性冠状动脉综合征预后的相关性研究 被引量:19

暂未订购
导出
摘要 目的:探讨缺血修饰白蛋白(IMA)与急性冠脉综合征(ACS)患者预后相关性。方法:选择ACS患者312例,所有患者测定入院时IMA,随访1年MACE。根据ROC曲线、Kaplan-Meier生存分析及Cox回归来分析IMA和ACS预后的关系。结果:随访1年中34例在1年的随访中发生MACE事件,其中12例为全因死亡;11例为非致死性心肌梗死;11例再次血运重建。MACE组IMA水平显著高于非MACE组(P<0.001);ROC分析IMA预测1年MACE的AUC为0.670;最佳阈值为61.96U/mL;Kaplan-Meier生存分析显示以IMA水平升高与1年预后密切相关(P=0.019)。Cox回归分析显示,引入相关危险因素校正后,IMA不是ACS独立危险因素。结论:血IMA水平及与ACS不良预后有关。但Cox回归显示IMA不是ACS1年MACE独立危险因素。
出处 《实用医学杂志》 CAS 北大核心 2013年第8期1278-1280,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献8

  • 1Sbarouniv E, Georgiadou P, Kremastinos 13. Ischemia Modified Albumin: Is This Marker of Ischemia Ready for Prime Time Use [J]? Hellenic J Cardiol, 2008,49(4):260-266.
  • 2李洁琪,何成毓,李晓翔,彭虹.心型脂肪酸结合蛋白和缺血修饰白蛋白对急性冠脉综合征的诊断价值[J].实用医学杂志,2010,26(23):4322-4324. 被引量:11
  • 3崔丽艳,刘迪,吴永华,张捷.缺血修饰白蛋白和C反应蛋白在急性冠脉综合征诊断中的作用[J].实用医学杂志,2007,23(21):3331-3333. 被引量:9
  • 4Worster A, Devereaux P J, Heels Ansdell D, et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome [J]. JAMA, 2005,172(3) : 1685-1690.
  • 5Aparci M, Kardesoglu E, Ozmen N, et al. Prognostic significance of ischemia modified albumin in patients with acute coronary syndrome [ J ]. Coron Artery Dis, 2007,18 (5) : 367-373.
  • 6Bali L, Cuisset T, Giorgi R, et al. Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes [J]. Arch Cardiovasc Dis, 2008,101 (10) : 645-651.
  • 7Quiles J, Roy D, Gaze D, et al. Relation of isehemia-modifi ed albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia [ J ]. Am J Cardiol, 2003,92 (3) : 322-324.
  • 8Garrido I P, Roy D, Calvino R, et al. Comparison of ischemia- modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals [J].Am J Cardiol, 2004,93 (1): 88-90.

二级参考文献27

共引文献18

同被引文献200

  • 1李莉.心脏标志物检测应用在早期急性心肌梗死患者诊断中的临床研究[J].医学信息,2017,30(6):284-285. 被引量:2
  • 2钟诚,任爱华.冠心病患者白细胞介素族的变化及其关系探讨[J].心血管康复医学杂志,2005,14(3):220-221. 被引量:11
  • 3陈灏珠.实用内科学[M].北京:人民卫生出版社,2002.1843.
  • 4A1 Suwaidi J, AI Habib K, Singh R, et al. Tobacco modalities used and outcome in patients with acute coronary syndrome: an observational report[J]. Postgrad Med J,2012,88(1044):566- 574.
  • 5Van Belle E, Dallongeville J, Vicaut E, et al. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study [J]. Am Heart J,2010,159(4):570-576.
  • 6Frank V,Bonney M,Bonney S,et al.Myocardial ischemia reperfusion injury-from basic science toclinical bedside.Semin Cardiothorac Vasc Anesth,2012,16:123-132.
  • 7Van Belle E,Dallongeville J,Vicaut E,et al.Ischemiamodified albumin levels predict long-term outcome in patients with acute myocardial infarction.The French Nationwide OPERA study.Am Heart J,2010,159:570-576.
  • 8Sbarouni E,Georgiadou P,Voudris V.Ischemia modified albumin changes-review and clinicalimplications.Clin Chem Lab Med,2011,49:177-184.
  • 9Aparci M,Kardesoglu E,Ozmaeu N,et al.Prognosticsignificance of isehemia modified albumin in patients withacute coronary syndrome.Coron Artery Dis,2007,18:367-373.
  • 10Worster A,Devereaux PJ,Heels Ansdell D,et al.Capability of isehemia modified albumin to predict serious cardiacoutcomes in the short term among patients with potential acute coronary syndrome.JAMA,2005,172:1685-1690.

引证文献19

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部